Pays: Indonésie
Langue: indonésien
Source: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
DUS,1 PREFILLED SYRINGE @ 0,5 ML (1 DOSIS)
2022-11-05
AVAXIM ADULT muscle of the buttocks (due to the presence of varying amounts of adipose tissue) nor intradermally, since these modes of administration may induce a lesser degree of immune response. LEAFLET KEMASAN: INFORMASI BAGI PENGGUNA AVAXIM ADULT INACTIVATED ADSORBED HEPATITIS A VIRUS Anda pernah pingsan dengan suntikan sebelumnya INACTIVATED ADSORBED HEPATITIS A VIRUS QUALITATIVE AND QUANTITATIVE COMPOSITION Each 0.5 mL dose contains: - Inactivated Adsorbed** Hepatitis A virus* . ................................................................ 160 ELISA units*** - Alumunium hydroxide (expressed as aluminium). .......... 0.3 mg - 2-phenoxyethanol. ......................................................... 2.5 µL - Ethanol. ........................................................................ 2.5 µL - Formaldehyde. ............................................................ 12.5 µg - Hanks 199 medium****. ........................................ up to 0.5 mL - Water for injections - Polysorbate 80 - Hydrochloric acid and sodium hydroxide for pH adjustment. - Less than 1 mmol of sodium and less than 1 mmol of potassium per dose * GBM strain cultured on MRC-5 human diploid cells. ** Adsorbed on hydrated aluminium hydroxide (0.3 miligrams of Al) *** In the absence of an international standardised reference, the antigen content is expressed using an in-house reference. **** Hanks 199 medium (without phenol red) is a complex mixture of amino acids (including phenylalanine), mineral salts, viamin and other components, including potassium. PHARMACEUTICAL FORM Suspension for injection (0.5 mL) in a prefilled syringe. The hepatitis A vaccine (inactivated, adsorbed) is a turbid and whitish suspension. THERAPEUTIC INDICATIONS This medicinal product is a VACCINE. - This medicinal product is recommended in the prevention of infection caused by hepatitis A virus in adults over the age of 16 years. - Vaccination against hepatitis A is recommended for subjects exposed to hepatitis A virus risks such as: * Non-immunized Lire le document complet